Ista Istalol Set For Launch In 8-10 Weeks; First Once-Daily Timolol

FDA clears once-daily timolol product for treatment of glaucoma. Ista's 28-rep sales force will target top 5,000 prescribers of ophthalmic beta blockers.

More from Archive

More from Pink Sheet